DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

06606 NH HEALTH

Suspend Add to Porfolio
Index Constituent : None
Major Shareholders Naxin YAO & Associates (8.43%)
Yiyou CHEN & Family (8.14%)
Qiming Corporate GP V, Ltd. (8.00%)
Invesco Asset Management Limited (6.56%)
Yeqing ZHU (6.27%)		 Sector Health Care & Biotechnology
Web Site https://ir.newhorizonbio.com Tel (86 571) 8110-7210
Email IR@nhbio.com.cn Fax (86 571) 8643-0935
Related Equities N/A
Principal Activities Principally engaged in research and development of screening products for colorectal cancer, cervical cancer and other types of cancer.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top